These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 20447185)
1. Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders. Blaes AH; Cioc AM; Froelich JW; Peterson BA; Dunitz JM Clin Transplant; 2009; 23(6):794-9. PubMed ID: 20447185 [TBL] [Abstract][Full Text] [Related]
2. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis. Vali R; Punnett A; Bajno L; Moineddin R; Shammas A Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450 [TBL] [Abstract][Full Text] [Related]
3. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring. von Falck C; Maecker B; Schirg E; Boerner AR; Knapp WH; Klein C; Galanski M Eur J Radiol; 2007 Sep; 63(3):427-35. PubMed ID: 17293073 [TBL] [Abstract][Full Text] [Related]
4. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder. Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883 [TBL] [Abstract][Full Text] [Related]
5. End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry. Zimmermann H; Denecke T; Dreyling MH; Franzius C; Reinke P; Subklewe M; Amthauer H; Kneba M; Riess H; Trappe RU Transplantation; 2018 May; 102(5):868-875. PubMed ID: 29189632 [TBL] [Abstract][Full Text] [Related]
7. The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients. Yang J; Zhuang H Hell J Nucl Med; 2015; 18(2):136-9. PubMed ID: 26187213 [TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease. Bianchi E; Pascual M; Nicod M; Delaloye AB; Duchosal MA Transplantation; 2008 Mar; 85(5):707-12. PubMed ID: 18337664 [TBL] [Abstract][Full Text] [Related]
9. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy. Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937 [TBL] [Abstract][Full Text] [Related]
11. Preliminary experience on the use of PET/CT in the management of pediatric post-transplant lymphoproliferative disorder. Guerra-García P; Hirsch S; Levine DS; Taj MM Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28612477 [TBL] [Abstract][Full Text] [Related]
12. The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder. Dierickx D; Tousseyn T; Requilé A; Verscuren R; Sagaert X; Morscio J; Wlodarska I; Herreman A; Kuypers D; Van Cleemput J; Nevens F; Dupont L; Uyttebroeck A; Pirenne J; De Wolf-Peeters C; Verhoef G; Brepoels L; Gheysens O Haematologica; 2013 May; 98(5):771-5. PubMed ID: 23065524 [TBL] [Abstract][Full Text] [Related]
13. Posttransplant Lymphoproliferative Disorder of the Thorax: CT and FDG-PET Features in a Single Tertiary Referral Center. Yoon GY; Kim MY; Huh JR; Jo KW; Shim TS Medicine (Baltimore); 2015 Aug; 94(31):e1274. PubMed ID: 26252295 [TBL] [Abstract][Full Text] [Related]
15. Both native and ectopically transplanted hearts shown on FDG PET/CT in a PTLD patient. Sonoda LI; Sanghera B; Gogbashian A; Lambert J; Wong WL Clin Nucl Med; 2012 Oct; 37(10):1022-3. PubMed ID: 22899204 [TBL] [Abstract][Full Text] [Related]
16. The value of Si Z; Lu D; Zhai L; Zheng W; Dong C; Sun C; Wang K; Zhang W; Wei X; Zhang Z; Zhao S; Gao W; Shen Z Pediatr Transplant; 2023 Aug; 27(5):e14501. PubMed ID: 36906739 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant. Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151 [TBL] [Abstract][Full Text] [Related]
18. PET-CT as an effective imaging modality in the staging and follow-up of post-transplant lymphoproliferative disorder following solid organ transplantation. Noraini AR; Gay E; Ferrara C; Ravelli E; Mancini V; Morra E; Muti P; Tahir A; Abdul Jalil N; Rossetti C Singapore Med J; 2009 Dec; 50(12):1189-95. PubMed ID: 20087557 [TBL] [Abstract][Full Text] [Related]
19. FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation. O'Conner AR; Franc BL Nucl Med Commun; 2005 Dec; 26(12):1107-11. PubMed ID: 16264358 [TBL] [Abstract][Full Text] [Related]
20. FDG-PET/CT in abdominal post-transplant lymphoproliferative disease. Metser U; Lo G Br J Radiol; 2016; 89(1057):20150844. PubMed ID: 26544161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]